Journal of Diabetes Investigation (Jan 2022)

Corneal confocal microscopy for the diagnosis of diabetic peripheral neuropathy: A systematic review and meta‐analysis

  • Hoda Gad,
  • Ioannis N Petropoulos,
  • Adnan Khan,
  • Georgios Ponirakis,
  • Ross MacDonald,
  • Uazman Alam,
  • Rayaz A Malik

DOI
https://doi.org/10.1111/jdi.13643
Journal volume & issue
Vol. 13, no. 1
pp. 134 – 147

Abstract

Read online

ABSTRACT Introduction Corneal confocal microscopy (CCM) is a rapid non‐invasive ophthalmic imaging technique that identifies corneal nerve fiber damage. Small studies suggest that CCM could be used to assess patients with diabetic peripheral neuropathy (DPN). Aim To undertake a systematic review and meta‐analysis assessing the diagnostic utility of CCM for sub‐clinical DPN (DPN−) and established DPN (DPN+). Data sources Databases (PubMed, Embase, Central, ProQuest) were searched for studies using CCM in patients with diabetes up to April 2020. Study selection Studies were included if they reported on at least one CCM parameter in patients with diabetes. Data extraction Corneal nerve fiber density (CNFD), corneal nerve branch density (CNBD), corneal nerve fiber length (CNFL), and inferior whorl length (IWL) were compared between patients with diabetes with and without DPN and controls. Meta‐analysis was undertaken using RevMan V.5.3. Data synthesis Thirty‐eight studies including ~4,000 participants were included in this meta‐analysis. There were significant reductions in CNFD, CNBD, CNFL, and IWL in DPN− vs controls (P < 0.00001), DPN+ vs controls (P < 0.00001), and DPN+ vs DPN− (P < 0.00001). Conclusion This systematic review and meta‐analysis shows that CCM detects small nerve fiber loss in subclinical and clinical DPN and concludes that CCM has good diagnostic utility in DPN.

Keywords